Upgrade to SI Premium - Free Trial

Merck (MRK) PT Raised to $74 at Goldman Sachs

July 27, 2017 6:54 AM
Goldman Sachs raised its price target on Merck (NYSE: MRK) to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change Hot Comments

Next Articles